Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock in […]